This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2012 Nov 7;308(17):1740-2.

doi: 10.1001/jama.2012.14491.

Inclusion of comparative effectiveness data in high-risk cardiovascular device studies at the time of premarket approval

Connie E Chen¹, Sanket S Dhruva, Rita F Redberg

Affiliations

PMID: 23117769
DOI: 10.1001/jama.2012.14491

Inclusion of comparative effectiveness data in high-risk cardiovascular device studies at the time of premarket approval

Connie E Chen et al. JAMA. 2012.

. 2012 Nov 7;308(17):1740-2.

doi: 10.1001/jama.2012.14491.

Authors

Connie E Chen¹, Sanket S Dhruva, Rita F Redberg

Affiliation

¹ Department of Medicine, Stanford Hospital and Clinics, Palo Alto, California, USA.

PMID: 23117769
DOI: 10.1001/jama.2012.14491

No abstract available

PubMed Disclaimer

Similar articles

Publication of Clinical Studies Supporting FDA Premarket Approval for High-Risk Cardiovascular Devices Between 2011 and 2013: A Cross-sectional Study.
Phillips AT, Rathi VK, Ross JS. Phillips AT, et al. JAMA Intern Med. 2016 Apr;176(4):551-2. doi: 10.1001/jamainternmed.2015.8590. JAMA Intern Med. 2016. PMID: 26902933 No abstract available.
Evidence strength in FDA premarket approval of cardiovascular devices.
Kong DF, Hasselblad V, Krucoff MW. Kong DF, et al. JAMA. 2010 Apr 28;303(16):1599-600; author reply 1600-1. doi: 10.1001/jama.2010.511. JAMA. 2010. PMID: 20424248 No abstract available.
Premarket clinical evaluation of novel cardiovascular devices: quality analysis of premarket clinical studies submitted to the Food and Drug Administration 2000-2007.
Kramer DB, Mallis E, Zuckerman BD, Zimmerman BA, Maisel WH. Kramer DB, et al. Am J Ther. 2010 Jan-Feb;17(1):2-7. doi: 10.1097/MJT.0b013e3181ca8105. Am J Ther. 2010. PMID: 20038828
The FDA's role in medical device clinical studies of human subjects.
Saviola J. Saviola J. J Neural Eng. 2005 Mar;2(1):S1-4. doi: 10.1088/1741-2560/2/1/001. Epub 2005 Feb 22. J Neural Eng. 2005. PMID: 15876645 Review.
Overview of the 2017 US Food and Drug Administration Circulatory System Devices Panel meeting on the Sentinel Cerebral Protection System.
Rogers T, Alraies MC, Torguson R, Waksman R. Rogers T, et al. Am Heart J. 2017 Oct;192:113-119. doi: 10.1016/j.ahj.2017.06.007. Epub 2017 Jun 23. Am Heart J. 2017. PMID: 28938957 Review. No abstract available.

See all similar articles

Cited by

A Policy Approach to Reducing Low-Value Device-Based Procedure Use.
Dhruva SS, Bachhuber MA, Shetty A, Guidry H, Guduguntla V, Redberg RF. Dhruva SS, et al. Milbank Q. 2022 Dec;100(4):1006-1027. doi: 10.1111/1468-0009.12595. Epub 2022 Dec 27. Milbank Q. 2022. PMID: 36573334 Free PMC article.
Assessment of Clinical Trial Evidence for High-Risk Cardiovascular Devices Approved Under the Food and Drug Administration Priority Review Program.
Jones LC, Dhruva SS, Redberg RF. Jones LC, et al. JAMA Intern Med. 2018 Oct 1;178(10):1418-1420. doi: 10.1001/jamainternmed.2018.3649. JAMA Intern Med. 2018. PMID: 30178044 Free PMC article.
Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device Supplements.
Zheng SY, Dhruva SS, Redberg RF. Zheng SY, et al. JAMA. 2017 Aug 15;318(7):619-625. doi: 10.1001/jama.2017.9414. JAMA. 2017. PMID: 28810022 Free PMC article.
Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
Varma N, Mittal S, Prillinger JB, Snell J, Dalal N, Piccini JP. Varma N, et al. J Am Heart Assoc. 2017 May 10;6(5):e005031. doi: 10.1161/JAHA.116.005031. J Am Heart Assoc. 2017. PMID: 28490521 Free PMC article.
How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
Samuel AM, Rathi VK, Grauer JN, Ross JS. Samuel AM, et al. Clin Orthop Relat Res. 2016 Apr;474(4):1053-68. doi: 10.1007/s11999-015-4634-x. Epub 2015 Nov 19. Clin Orthop Relat Res. 2016. PMID: 26584802 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems